Cellectis (CLLS) Return on Capital Employed Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | 68,255.00 |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 2,665.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | 31,429.00 |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 2,503.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -105.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | 2,400.00 |
| 10 | Cellectis | 20.83 Bn | 20.62 Bn | - | -54.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -54.00 |
| Dec 31, 2025 | 907.00 |
| Sep 30, 2025 | 2,006.00 |
| Jun 30, 2025 | 1,635.00 |
| Mar 31, 2025 | 2,596.00 |
| Dec 31, 2024 | 5,662.00 |
| Sep 30, 2024 | 743.00 |
| Jun 30, 2024 | -56.00 |
| Sep 30, 2023 | -365.00 |
| Jun 30, 2023 | -115.00 |
| Sep 30, 2022 | -102.00 |
| Jun 30, 2022 | -666.00 |
| Sep 30, 2021 | -1,555.00 |
| Jun 30, 2021 | -1,158.00 |
| Mar 31, 2021 | -925.00 |
| Dec 31, 2020 | 950.00 |
| Sep 30, 2020 | 538.00 |
| Jun 30, 2020 | 549.00 |
| Mar 31, 2020 | 199.00 |
| Dec 31, 2019 | -739.00 |
| Sep 30, 2019 | -441.00 |
| Jun 30, 2019 | 37.00 |
| Mar 31, 2019 | 1,207.00 |
| Dec 31, 2018 | 887.00 |
| Sep 30, 2018 | 869.00 |
| Jun 30, 2018 | 152.00 |
| Mar 31, 2018 | -1,140.00 |
| Dec 31, 2017 | -815.00 |
| Sep 30, 2017 | -1,460.00 |
| Jun 30, 2017 | -1,050.00 |
| Mar 31, 2017 | -572.00 |
| Dec 31, 2016 | -1,184.00 |